title: Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
authors.affiliation: Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Division of Endocrinology, University of Cincinnati College of Medicine Cincinnati, Ohio, USA.
authors.forename: Philippe
authors.initials: P
authors.lastname: Backeljauw
mesh_terms: D001827:Body Height; D002648:Child; D019317:Evidence-Based Medicine; D006130:Growth Disorders / Q000188:drug therapy*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000172:deficiency* / Q000378:metabolism / Q000627:therapeutic use*; D046150:Laron Syndrome / Q000188:drug therapy*
chemical_list: D007334:Insulin-Like Growth Factor I